Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Enterprise Value (2016 - 2026)

Nutex Health (NUTX) has disclosed Enterprise Value for 17 consecutive years, with -$114.9 million as the latest value for Q1 2026.

  • For Q1 2026, Enterprise Value fell 1128.52% year-over-year to -$114.9 million; the TTM value through Mar 2026 reached -$114.9 million, down 1128.52%, while the annual FY2025 figure was -$91.9 million, 834.28% down from the prior year.
  • Enterprise Value hit -$114.9 million in Q1 2026 for Nutex Health, down from -$91.9 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $12.5 million in Q4 2024 and bottomed at -$114.9 million in Q1 2026.
  • Average Enterprise Value over 5 years is -$24.2 million, with a median of -$14.6 million recorded in 2022.
  • Year-over-year, Enterprise Value soared 387.72% in 2024 and then plummeted 1128.52% in 2026.
  • Nutex Health's Enterprise Value stood at -$9.8 million in 2022, then surged by 55.58% to -$4.3 million in 2023, then skyrocketed by 387.72% to $12.5 million in 2024, then crashed by 834.28% to -$91.9 million in 2025, then dropped by 25.03% to -$114.9 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$114.9 million, -$91.9 million, and -$45.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.